Clinical trials
Phase 2 Lymphoma, Non-Hodgkin trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 4 |
| MedImmune LLC | 2 |
| Amgen | 1 |
| Bayer | 1 |
| German High-Grade Non-Hodgkin's Lymphoma Study Group | 1 |
| Gilead Sciences | 1 |
| Hoffmann-La Roche | 1 |
| MEI Pharma, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Miltenyi Biomedicine GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 17 |
| Lymphoma | 7 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Lymphoma, Follicular | 4 |
| Recurrence | 3 |
| Hematologic Neoplasms | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Waldenstrom Macroglobulinemia | 2 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.